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Mary Russell was one of 30 young people taking part in the Program in Occupa
tional Therapy's summer Di sco very Program. At the St. Louis Zoo, she experi
enced some of the consequence s of using a wheelchair. The program brings high
school and college students interested in careers in occupational therapy to the
medical school campus for a week to help them make more informed career
choices. The students, from across the country, are exposed to occupational therapy
as it applies to pediatrics, physical disabilitie s, mental health and independent
living.
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ohn Atkinson, M.D .,
has been named chair
man of the Department
of Internal Medi cine. The
appointmen t. effect ive Oct.
I, 1992, was a nn ounced by
William A. Pec k, M.D. , vice
c han cellor fo r medica l af
fa irs a nd dean.

J

John Atkinson, M.D., newly
appointed chairman of the
Department ofIntemal
Medicine.

Atk inso n repl aces David
M . Kipnis, M.D ., profes sor
of medicine, wh o has held
the pos ition sin ce 1973 .
Kip nis has been appoin ted
Di stingui shed Univers ity
Professor of Medicine and
will divide hi s future ac tivi
ties among expan ded re 
search efforts in di abetes
mellitu s, undertakin g special
proj ec ts fo r the Departmen t
of Medi cine and the dean
and in creased involvement in
co rporate and foun dati on
2

Ilead ()f
interac ti ons with the medi cal
sch ool. (See the "Silhoue tte"
later in thi s edition.)
'The De partment of
Medicine at Was hington
University has a long tradi
ti on of outstandin g leaders,
mos t recentl y David M.
Kipni s. Hence, the depart
ment has beco me one of the
best in the nati on, recog 
ni zed for the sc ientific , edu
ca ti onal and clinical
co ntribution s of its superb
fac ulty . John Atk inson has
the tal ent to build on that
tradition well into the 21 5t
ce ntury. He is a world -c lass
investi gator, a ren owned
teac her and a superb clini
cian wh o has the respect and
admirati on of students,
house st aff, trainees and fac
ulty, " Peck says.
Atkin son, profe ssor of
medi cine and molec ul ar mi 
c robiology, wi II leave hi s
post as director of the
rheum atology divi si on.
Louis Simchowitz, M.D.,
professor of medicine, will
serve as the divi sion's in 
terim director. Atki nso n will
continue his research on the
structure , fun ction and ge
netics of the co mplement
system , a group of proteins
of the immune sys tem .
Atkinson's researc h has
played a key role in definin g
how the co mplement sys tem
is activ ated and in ways to
control the damage co mple
ment protei ns sometimes
cau se by attac king the
body's cell s.

Atkinson joi ned the
Was hington Universit y fac
ulty as an assistant professor
of medi cine and head of the
rheumatology di vision in
1976. He beca me a full pro
fe ssor in 1984 . Sinc e 1976
he has been an inv esti ga tor
for the Howard Hughes
Medica l In stitute. The in sti
tute support s medical sc ien
tists at academi c medical
centers and uni vers ities
throughout the United States.
Atkinson serves on the edito
ri al boa rds of four medi ca l
journals, including the Jo ur
nal of Immunology and the
Annals of Int ern a l Medicin e .
Atkinson received hi s
bac helor's degree from Kan
sas University in 1965 and
hi s medi ca l degree from th e
same instituti on in 1969. He
completed hi s internship and
res idency at Massac husett s
Ge neral Hospi ta l. •

C]ollinger
Honol'ed \"itb
Awar{ls
Robert Cloninge r,
M.D., Wallace
• Re na rd Profes so r
and head of the Department
of Psychiatry, is one of two
rec ipients of thi s year' s
Jam es B. Isaacs on Memorial
Award. The award was pre
sented at the meeting of the
Internati onal Society for
Biomed ica l Researc h on Al
coholi sm in Bristol. England.
Cl oninger shares the
awa rd with Michael Bohma n
of Umea, Sweden . The tw o

C

have work ed together on
adopti on studies in
Scandinavi a a nd are being
honored for their work on
genetic risk factors fo r alco-

Recipient of the James B.
Isaacson Memorial A ward,
e. Robert Cloninger, M.D.
hoi is m. They share the
fourth Isaacs on award ,
whic h was created in 1986 to
honor sc ie nti sts whose re
search contributi ons are cru
cial to basic or c lin ica l
medical adv ances in a lcohol
ism and dru g abuse .
Cl oninger and Bohman ' s
adopti on studies allowed
them in 198 1 to identify two
types of al co holi sm. In type
I , the more prevalent , drink
ing begins in ea rl y adult
hood, causes medi ca l
pro blem s in later life, and is
cau sed by both genetic s and
en vironme ntal factors . In
type 2, whi c h us uall y occurs
in men and ofte n in crimi
na ls, genetic tendencies are
the prima ry cau se.
C lo nin ge r has investi 
gated the genetic epidemi ol
ogy of alco holi sm,

schizophrenia and mood di s
orders among other psychiat 
ri c disord ers. In researching
the genetic and environmen 
tal causes of the variou s dis
orders, he has studied
sa mpl es from the general
popul ation s of the U.S .A. ,
U.S.S.R, italy , Japan and the
Scandinavian co untries.
Clonin ge r rece ntl y wa s
prese nted with th e Mortimer
Goodman Award by the Alli 
ance for the Mentally il I of
St. Loui s in recog nition of
outstanding se rvice to the
alliance. He was cited in par
ti c ular for his commitment to
service in the public sector.
He is psyc hiatrist-in-chi ef at
Barnes Hos pital and is a
staff physician at Jewi sh and
St. Lo uis Children 's hospi
tal s at Washin gton Unive r
sity Medical Center. n
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aniel E. Goldberg,
M.D. , Ph .D , assi s
tant professor of
medicine and molecular mi 
crobiology, is one of three
scientists chosen to receive a
Charles E. Cui peper Fou nda
tion SCholarship in Medical
Science for 1992.
The foundati on's sc ien
tific ad visory co mmittee
chose the sc holars from

D

among more than 50 appli
cants nomin ated by their in
stitutions. In addition to
Goldberg, Peter M. Glazer,
M.D. , Ph.D., of Yale Univer
sity Schoo l of Medicin e, and
Keith Most ov, M.D., Ph.D.,
of the Universit y of Califor
nia , San Franci sc o, were
chosen as Culpeper scholars.
The awa rd provi des
Goldberg with $ 100,000 per
year for three years to fund
his research on alternative
drug therapy to combat ma
laria, a para sitic illness that
kills 2 million peop le annu
ally. Goldberg will work to
further define the metaboli c
processes critical to the sur
viv al of malaria parasites.
The informati on is cr ucial
for hi s attempts to engin eer
novel mol ecule s that starve
the parasite by shutting off
its energy pipeline. The goal
of the work is to provid e a
much-needed alternative to
the current inadequate ma
laria therapy, Goldberg says.
The Charles E. Culpeper
Foundation Scholarships in
Medical Scie nce program
was established in 1987 as
an exte nsi on of the
foundation ' s ongoing com
mitment to medical sci ence .
Since the sch olarship pro
gram began, 15 investigators
representing med ical schools
from all parts o f the United
States have received aw ards .
The Culpeper Foundati on
was esrabl ish ed und er the
will of the late Ch arles E.
Culpeper, a pion ee r in the
bottling and marketing of
Coca-Cola . •
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av id c. Van Essen ,
Ph.D., formerly
pro fe ssor of biology
at the California institute of
Techno logy, has been ap
pointed profes sor and he ad
of the Department of
Anatomy and Neurobio logy.

D

David C. Van Essen, Ph.D.
Van Essen is widely rec
ognized for his resea rch on
how the brain org anizes and
processes v is ual in format ion.
Hi s studies in primates have
helped to demon strate that
more th an 20 areas in the
cerebral cort ex are respon 
sible for processing vi sual
in formation . Using the t061 s
of neurophy siology and
computati onal neurosc ie nce ,
Van Essen's research has
clari fied how the various ar
ea s of the brain work inde
pe ndently and togeth er to
create the process of seein g.

Anatu.uy

The work of Van Essen
and other neuroscientists has
dem onstrated that there are
two general strea ms of infor
mation in the visual co rtex :
one dealing with fine detail
and color , the other with
movement and orient a tion in
space. Van Essen' s current
research involve s a variety
of ph ys iologi ca l and beha v
ioral experiments to define
whi ch areas of th e brain con 
trol a particular perce ption,
such as mot ion or color.
"As an internationally
recognized neurosci e ntist,
Dr. Van Es sen represents a
maj or addition to one of the
stron ges t neurosc ience pro
gram s in the world," say s
William A. Peck, M.D. , vice
chancell or for medical af
fairs and dean of th e School
of Medicin e. "Dr. Van Essen
is an aw ard-winning teac her
with adm in istrati ve talent ,
and he will be an ex cell ent
le ader for a grea t depart
ment."
Van Esse n received hi s
graduate degree in neurobi
ology in 197 1 from Harvard
Medi ca l Sc hool. He was a
postdoctoral fellow at
Harvard under David H.
Hubel and Torsten N.
Wi ese l, who shared the No
bel Pri ze in Medicin e in
1981 for their work on how
mam malian brain cells ana
ly ze vi sual information. •
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nder a five-year
collaborati ve agree
ment with S phinx
Pharmaceuticals Corpora
tion, the School of MedicIne
will receive $5 million to
develop new treatments for
cardiovascular and inflam
matory diseases. Richard
Gross, M.D., Ph.D., profes
sor of medicine, chemIstry,
and of molecu lar biology
and pharmacology, will lead
the proJect.

U
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ecules that effect a wide
range of essential functions
throughout the body. In heart
cells, these regulators cause
the tissue damage and ir
regular heart rhythm that ac
company heart attacks. They
also are believed to contrib
ute to inflammation in sev
eral tissues.
One goal of Gross' re
search is to find inhibitors
for PLA 2 that will stop
arachidonic acid release and

Richard Gruss, M,D., Ph.D. , will direct research ill colla ho
ration with Sphinx Pharmaceuticals Corporation.
The collaboration will
su pport research focused on
developing dru gs to control
enzymes called phospholi
pases A2 (PLA 2), thought to
playa key role in heart at
tack, stroke, atherosclerosis,
arthritis, asthma and other
diseases.
PLA 2 enzymes cause the
release of arachidonic acid,
which is converted into sev
eral potent regulatory mol

avoid the "downstream"
problems it cuLloCS. "What
we are aiming for is a drug
that operates at the begin
lllng of thIS cascade to treat a
multiplicity of problems with
a single agent," Gross says.
Gross will focus on the
three ['orms of PLA 2 known
to exist inside cells. He and
his colleagues discovered
two of these "intracellular"
forms in 1985 and 1986.

PLA 2 enzymes produced out
side the cell have long been
a research target but so far
have not yielded useful
drugs, Gross says. Studies
over the past decade by
Gross and others suggest that
these i ntracell u lar forms are
more likely to be the rel
evant pharmaceutical targets,
he says. "We have very high
hopes that successfu I agents
can be found using these in
tracellular phospholipases A,
as probes to identify medici-
nally useful compounds."
Under the terms of the
agreement, Sphinx will con
tribute at least $5 million to
support the project during
the next five years. Sphinx
will receive licensing rights
to two pending university
patents and will hold licens
ing or option rights to the
university's interest in future
patents that arise from the
research. In addition, Sphinx
will hold exclusive develop
ment and marketing rights to
candidate drugs that result
from the collaboration. The
university will receive a roy
alty on future product sales.
"We are pleased to enter
into a research and develop
ment collaboration with Dr.
Gross, who is one of the
world's experts in the field
of PLA,," says Clayton I.
Duncan', Sphinx president
and CEO. The Durham, NC,
company is an industry
leader in developing thera
peutic drugs aimed at lipid·
related enzymes. Its research
programs focus on treat
ments for cancer, cardiovas
cular disease and
inflammatory disorders . •
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treptococcal bacteria
know that success in
life is a sticky busi
ness. They have a remark
able ability to cling to throat
cells with such avidity that
monsoon-I ike sneezes and
oceans of saliva fail to dis
lodge the bugs. And major
illnesses like strep throat,
pneumonia and scarlet and
rheumatic fever are the result
of this bug's penchant for
our throats.
When streptococci float
into the throat and anchor
themselves, infection is vir
tually guaranteed. Until re
cently, scientists did not
understand how streptococci
cling to the throat. '\low, in
Proceedings of the Notional
Academy of Sciences, scien
tists here report that they
have discovered the key pro
tein that group A strepto
cocci use to grip cells.
Without protein F, strep
tococci can't cause strep
throat, pneumonia or rheu
matic fever. '>ays the paper's
lead author, M ichael G .
Caparon, Ph. D., assistant
professor of molecular mi
crobiology. The new evi
dence shows that
Streptococcus pyogenes
uses thousands of these pro
teins as tentacles to reach out
and seize fibronectin recep
tors. Fibronectin is a sturdy,
fibrous protein that is well
connected to tbe meshwork
that anchors cells, making it
an appealing target for in-

:.'---- - -- -_ ____-----:-----_ _

~------"J-

vading bacteria. Protein F
grips fibronectin wi th a ho ld
stron g eno ugh to withstand
the coughs, sneezes and sa
li va that normally sweep
away untethered bacteria.
Prote in F might as well be
super glu e, judging from 20
to 30 million new cases of
group A strept ococca l infec
ti on each yea r in th e United
States. That rat e of success
translat es into million s of
days spent out of school or
o ut of work for those in
fected.
Usually , penicillin is
eno ugh to stop the infection
before strep make life co n
sid erably more miserable.
A lthou gh res earc hers ha ve
yet to encount er penicillin
re sis ta nt streptococci, they
predict th at it won ' t be long
before such strai ns are ma k
ing the round s. Dru g-res is
tant strep co uld be a disaster,
Ca paro n co ntends . Without
treatment, streptococ ca l in
fec tion ca n progress to pn eu
monia or rheumatic fever, a
disea se that can destroy deli 
cate heart valves.
Word from the front li ne s
of researc h is even more
ominous. Seve ral types of
strep tococci that di rec tl y
penetrate the ski n to cause a
devasta tin g toxi c shock-like
illn ess rece ntl y have been
isola ted. This bad new s un
de rllll es th e importan ce of
drugs th at the bacte ria can't
o ut smart. Theoretically , the
di scove ry of protein F gives
sc ie ntists a bett er cha nc e at
des igning drug s that can stop
stre p adh esi on to health y
ce ll s. An "an ti-adh esi ve"

approach cou Id work,
Caparon says, but there's
much mo re resea rc h to do
before "no-st ick" pill s arri ve
on the ph armacis t's shelf.
For now, th e exc item ent
of th e discovery remain s in
th e sc ientifi c co mmunity
wh ere - fo r the first ti me 
sc ientists have a genuin e
streptococcal ad hes in to
wo rk with. Sci enti sts ha ve
sought strep's ad he sive pro
tein for years, but it re
mained elu si ve because too ls
could n' t keep pace with
ideas. Many model s of strep
tococcal adhe ren ce ha ve
been proposed, but all ha ve
been swept away by further
research , Ca paron notes.
The short shelf life of past
ad herence th eories gi ves
Capa ron a healthy skepti
cism abo ut hi s find. Thoug h
he knows he has identified
an adhesion protein, Caparon
remain s uncon vinced th at his
theory will stick. " It see ms
too cl ean." he says. " Bacte
rial adherence is such a co m
plicated phe nomeno n that
th e protein F model seems
too neat. Is thi s the last
word? It 's difficult to say.
Wh e n anyone else has tri ed
to mak e suc h strong con clu 
sions, th ey have al ways
even tu ally been shown not to
be the case." •
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ichael 1. Wel ch,
Ph .D. , professo r of
radiology an d di
rec tor of radiati on sciences
at Was hington University's
Mallinckrodt In stitute of Ra 
diology, is the recip ient of
the Soc iety of Nuclear
Medi ci ne' s (SN M) Thir
teent h Annual Georg Charles
de Hevesy Nuclear Medicine
Pi oneer Aw ard.

rad iopha rm ace utical i magi ng
age nts provi des a bas is for
clinic al research studie s on
breast tumor locali zat ion and
brain neurorecept ors.
Th e Georg Cha rles de
He vesy Nu clear Medi ci ne
Pi oneer Award was es tab
li shed by the SNM in 1960
in honor of Georg Charles de
Heve sy, a Hungari an chem 
ist who developed ra
diotrac er techniques. The
a ward ee is chosen annuall y
by the president of th e SNM,
based on his or her ove rall
accom pli shments in and con-

Michael]. WeLch , Ph.D., receives the Society ufNuclear
Medicine's 13th AllnuaL Georg de J/evesy NlIclear Medicine
Pioneer A ward f rom Leoll S. Malmud, M. D., president of the
society. In the cellier is William C. Eckelmall, Ph.D., Was h
ingtoll Ull ivl!Tsily allill/l//1 .~ lIlId director of PET at the NIH.
Welch 's work on the
rap id synthes is of positron
labeled orga ni c c hem ica ls
was of vital importance in
th e appli ca tion of posi tron
e mission tomograp~y (PET)
in di ag nost ic medic in e.
We lch applies modern
orga nic chem istry to th e pre 
paration of radiop harm ace u
tical s used in medical
imaging. Hi s production of

tributions to the fiel d of
nuclear med icin e. Mallinck
rodt Institu te' s M ichel M.
Tcr-Pogossian , Ph.D., a de
ve lope r of positron e mi ss ion
tomog rap hy, was rhe 1985
award wi nn er. We lch re
cei ved th e award in Los An
geles on June 9, during the
SN M' s aIlnu al meeting.
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taffan J. Normark,
M.D., Ph.D. , professor
and head of the De
partment of Molecular Mi
crobiology, is the recipient
of the Goran Gustavsson
Award in Medicine be 
stowed by the Royal Swed 
ish Academy of Sciences.

S

Staffan j, Normark, M,D"
Ph,D,
The three-year, $500,000
award is named for Goran
Gustavsson, a Swedish phil
anthropist who donated $60
million to the Royal Swedish
Academy of Sciences in
1990 to reward outstanding
achievement in medicine ,
molecu lar biology, phys ics,
chemistry and mathematics.
A committee at the academy
selec ts award winners from a
group of sc ientists nomi
nated by it s members.
Normark was awarded the
prize in medicine for his
contributions to the under
standing of how bacteria
cause disease. The award

6

money will be used to fur
ther hi s research .
During more thilll 20
years of research, Normark
has studied many types of
bacteria, especially £. col i, a
bacterium commonly in
volved in urinary tract infec
tion s and seps is. Although £.
coli is a regular inhabitant of
the intestinal tract, when it
spills into the blood or grabs
hold of cells lining the uri
nary tract, it can becom e a
major medical problem. The
adhesive mechanisms that £.
cali use to adhere to cells
and initiate disease are not
well understood, but
Normark says the adhesins
are a target for drug therapy.
Normark and his colleagues
in Sweden and the United
States are currently develop
ing "a nti-adhesive" drugs to
pre ve nt bacteria from attach
ing to healthy cells.
Studying how bacteria
protect themsel ves from host
defenses and therapeutic
drugs is another project des
tined to improve current
drug de sig n. Mutant strain s
of bacteria are resistant to
the be st antibiotics in the
medical arsenal , and genetic
studies in Norrnark's labora
tory are yielding new in sight
into how bacteria become
resistant. The research is
currently supported by the
National Institutes of Health
and pharmaceutica l compa
nies.
Normark, a native of
Sweden, came to the School
of Medi c ine in 1989 from
the University of Umea,
where he was a professor of
medical microbiology.
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teve n L. Leary,
D.V .M. , ha s been
named assistant vice
chancellor for veterinary af
fairs and director of th e divi
sion of co mparative medicine.

S

Stel'en L. Leary, D. V.M"
assistant vice chancellor for
veterinary affairs.
Leary 's appointment, ef
fective August 1, was an
nounced by Theodore J.
Cicero, Ph.D., associate vice
chancellor for animal affairs
and associate dean of the
School of Medicine.
"We are de lighted to have
Dr. Leary join our faculty,"
says Cicero. "He has an im 
pressive background in re
search and extensi ve
experience in the planning
and designing of animal re
sea rch facilitie s."
Leary comes to St. Loui s
from the University of Ala
bama at Birmingham, where
he was a professor of com

parative medicine and direc
tor of the animal resourc es
program. He will provide
guidance on the care and use
of animal s at the university
and will participate in deci
sions regarding the animal
program and its facilitie s and
procedures.
Highly regarded for de
veloping and maintaining the
animal resource s program at
A labama- Birmingham,
Leary's resea rch interests are
in arthritis, cancer and the
comparative pathology of lab
animals. He joined the fac
ulty at the Univ ersity of Ala
bama-Binningham in 1986.
Earl ier, he served on the fac
ulty at the University of
Minneso ta in the College of
Veterinary Medicine and as
a veterinary consultant at the
Veterans' Admini stration
Health Center in Minneapo
li s. He also has worked as a
regional veterinary officer
for Papua, New Guinea and
has practiced veteri nary
medicine in Iowa and Illi
nois.
For the past three years,
Leary has served on the ac
creditation council of the
American Assoc iation for
the Accreditation of Labora
tory Animal Care and since
1990 he has been a member
of the task force on future
directions of laboratory ani
mal medicine for the Ameri
can College of Laboratory
Medicine.
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eponing the res ult s
of a four-yea r study ,
researchers here
have de mon strated for the
fi rst ti me that antid epres sa nt
drugs can successfu Ily treat
clinical depress ion in dia
betic pati ents.
In th e past , although doc
tors may have pre scr ibed
antidepre ssa nt drugs for th eir
di a betic patient s with de
pression, there was no proof
that th e therapy would be
effec tive because diabetic
patients metabo li ze some
dru gs differently than tho se
with norm al blood g lucose
leve ls.
Depressi on is common in
diabetic patients, according
to Patri ck 1. Lu stman, Ph.D.,
associate pro fesso r of medi
ca l psychol ogy. "Di abetic
patients are about three times
as lik ely to suffer from ma
jor depress io n, and it' s oft en
worse for them th an for non
diabetic patients. In de
presse d peop le wh o aren't
diabetic. the symptoms te nd
to com e and go. Di abeti c
pati e nts get de pressed and
stay depresse d," say s
Lu stman.
Though their symptoms
are more de bilitatin g,
Lustman says, " De press ion
is und er-recog nized in dia
bet ics. Abo ut two-thirds of
the internists who treat dia
beti c patients don't recog
ni ze or trea t depress ion."
Those who do ge t antid e
pres sa nt drug s usually re
ceive the med icati on not for
de pression but for treatm ent

lIel., Iliabetit·
Palit'nt!o;
of diabeti c neuropath y.
Lu stman says tri cyc lic anti
depressant dru gs have bee n
proven effec ti ve as analge 
s ics , but until now had neve r
been studied to see if th ey
actu a l Iy worked as treatment
for depress ion in diabetics.
The new insight was re
ported at the 52nd Annual
Conference of the American
Diabetes Association in San
Antoni o, TX.
Studying patients with
poor glu cose control and ma
jor depres sive disorder,
Lu stman and his team found
th at diabetic pati ents receiv 
ing the antidepress ant drug
nortriptylin e for eight weeks
were significantly less de
pres sed than those who re
ceived placebo.
The antidepressa nt medi
ca tion did not control blood
glucose levels as inves tiga
tors had hoped it might,
though so me of Lustman ' s
other work suggest s that ef
fe cti ve treatment for depres 
sion could result in bett er
lon g-term bl ood glu cose
man age ment. In a se parat e
study on depres sion and
blood g lucose manageme nt,
Lu stman and co-investiga
to rs found that de pressed
diabeti c pati ent s often have
probl ems with glu cose le ve ls
si mply because th ey aren't
as likely to comply with
th eir presc ribed treat ment
reg imen.
"Dep ressed patients are
less likel y to monitor their
blood g lu cose le vels as th ey
should," says Lustman. He

spec u lates that manage ment
of depress ion with nortript y
line could hav e the added
bonu s of lead ing to better
ove rall disease manageme nt
for diabetic pati ents . •

Gordon
Re(O("iv(·s
I)i~ tinguished
A.·hieveulenl
Awur(1

T

he American
Gastroenterological
Assoc iation has pre
se nted the Distinguished
Achievement Award, it s
hi ghes t hon or for an investi
gator, to 1effre y I. Gordon ,
M.D., alumni endowed pro
fe ssor and head of the De
partment of Mol ec ular
Biology and Ph armacol ogy.
Gordon ' S laboratory em
pl oys transgenic mice to ex 
amine the mech anism s that
allow the int estine to acquire
diffe rent functions in its
va rious pans and hO\~ gut
epitheli al cell s differentiate
from stem cell prec ursors.
Gordon an d hi s co lleagues
also use genetic, bioche mical
and organic c hemi ca l tools
to examine an enzyme called
N-myristoy Itrans fera se
(NMT) that attaches myristi c
ac id (a rare fatty ac id) to
prot ein s important in regu
latin g cell growth , the viabil
ity of fun gi that ca use a

vari e ty of infec tious diseases
and th e asse mbl y of cert ain
viruses.
These studies have al
lowed them to develop a new
group of compound s that
inhibit repli ca tion of the
AIDS virus in human white
blood ce lls in th e laboratory.
Th e new co mpound s re
se mble myristic ac id and are
tran sfe rred by NMT to pro
teins of th e AIDS virus 
blocking the virus ' ability to
assemble. Th ese compounds
also may be use ful for treat 
in g other infectiou s agents
a nd may affect other
path o logic con dition s, such
as ca ncer .

Jeffrey I. Gordon, M.D.

Gordon has rece i ved sev 
eral other awards for hi s re
search, includin g the
American Federati on for
Clinical Research Youn g
Investiga tor Award anel the
National In sti tute of Diabe
tes and Di ges ti ve and Kid
ney Di seases Yo un g
Scie ntist Awa rd.
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by Kleila Carlson

Jlew
maller in diameter

S

than a toothpick, a
woman's fallopian

tubes are significant out
of all prop rtion to their
size. They are the tunnels
through which eggs must
travel to the uterus after

Assessing
The
Falloposcope's
Potential

being released by the
ovary and so are an essen
tial pathway in the com
plicated process of
fertilization. Blocked by
tubal disease -

co mmon

in American women 
these tiny tub s are at the
root of the frustrating and
emotional infertility di
lemma suffered by mil
lions of couples.
8

The same minus cul e size th at makes
fallopian tubes susce ptible to blockage
makes it difficult and so metimes
imposs ible to accurately diagnose tubal
disease. Whe n di sease occurs in the
small est seg me nt of the fall op ian tube ,
as it does one-thircl of the time , it has
been imposs ibl e to view because the
one - to two-centim eter diameter there is
simply too small.
Th e aptly named fall oposco pe - a
new diagn ostic tool being investigated at
the Sch oo l o f Medi cine - may ma ke it
possible for ph ysicia ns to explore what
Da ni el B. WiJjiams, M.D, ca lls the
"narrow and tortuo us" reg ion of the
fa ll op ian tube known as the proximal
porti on. Th e in strument may one day

take the pl ace of laparoscopy to perfor m
tec hniques commonly used to help
i nfe rti Ie cou pies concei ve. Procedures
suc h as gamete intrafall opian transfer
(GIFT), and zygote intrafall op ian
transfer (ZIFT) , both of which require
gentle manipul ati on to place the sperm
and egg in side th e fallopian tube , may
someday be perform ed us ing a
falloposcope.
Earl y results of a multi ce nter study
exa mining the sa fe ty and effecti veness
of the instrume nt a nd how it is placed
into the fall opia n tube show promi se.
Researchers are optimistic they will
hav e the potential to perform delicate
surgery and diagnose tuba l disease
tran sce rvica ll y (through the cerv ix) ,
eliminating the need for major surgery .
"The fall oposco pe wi ll allow us to do
a number of things we c urrently cannot
do ," says William s, in stru ctor in
obstetrics and gynecology and principal
inv es tiga tor of the study he re . ,·it allows
us to view disease, such as tubal
adhesions, whi ch we may be able to
re mov e with very s mall lasers. We ca n
assess the inside of th e fallopian tube
and in form patients ahead of time about
their potential risk of ecto pi c (tubal)
pregnancy. Thi s is somethin g we ' ve

Daniel B. Williams, M.D., displays the
falloposcope, a device that makes it
possible to view the narrow and
tortuous fallopian tubes.
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ne ver been able to do before, because we
couldn't clearly visuali ze the earl y part
of the fallopi an tube."
Williams, who came to St. Loui s
from California just over a year ago, has
been working with th e falloposcope for
the past two years. He helped refine the
technology while he wa s a fellow at
UCLA- Cedars Sinai Hosp it al in Los
Angeles. Late last year, th e Sc hool of
Medicine was approved to take part in a
multicenter Food a nd Drug Administra
tion (FDA ) tria l to tes t the in strume nt 's
safety and effectiveness. It is the onl y
center in Missouri invo lved in the
project; institutions in the United States
and Europe are tak in g part in the clinical
study.
Williams' study involved 10 women
who were already undergo in g laparo
scopy for infertilit y. Two women had
blocked tubes as a res ult of proximal
tubal di sease, and two had norm al tubes.
Tubal dy sfunctio n was eliminated as the
ca use o f infertility in those with normal
tubes.
According to William s, the proximal
portion of the fallopi an tube, which
extends ou tward from th e uteru s, is
frequently the site of obstru ctive disease .
"Roughly 30 percent of all tubal disease
results from proximal occ lu sion," he
says. "Until now, we hav en't been able
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to adequatel y assess thi s segment
because it was too small to view. The
diameter of the proximal porti on is one
to two millim eters or abo ut one- third the
diameter of the ampu ll a (w here fe rtiliza
tion occurs in the fallopian tube), which
is about six millim ete rs. It was difficult
to develop a sco pe that could negotiate
this particular region of th e tube while
providin g good imaging."
Because endoscopes have been
unable to reac h thi s area, phy sicia ns
previ ous ly diagnosed tu ba l di sease by
radi ogra phi c imaging lI sing radi opaque
dye. Williams says such tests are limited
because they don ' t identify the type of
tubal blockage or detect the presence of
potenti all y damagi ng le sions that aren' t

"At least 30 percent
of all infertility is
the result of tubal
disease."

obstructive. " In order to provide proper
treatment , we need to be ab le to di stin
guish between diseased tubes th at are
blocked due to inflamma ti on or fibros is
and tubes that are plu gged by mucus or
tubal spasm."
A large percent age of the tu bal
damage William s sees re sults from
chlamydia and go norrhea, both of which
are sexually tran sm itted diseases that
ca n induce tu ba l damage or lead to
damag ing infection s that may ca use no
outward sy mptoms in the pati e nt. "Tubal
disea se is one of the major ca uses o f
infertilit y," William s says, add in g that
an estimated 3 million coupl es are
affected by some for m of infertility. "A t
least 30 perce nt of all infertility is the
result of tubal disease ."
Falloposcopi c tech niques to diagnose
and treat th e damage th at can result from
tubal infe ct ion have been undergoing
refinement sin ce the late 198 0s. The
actual scope tha t see ks ou t the injury is a
miniature version of the in strume nt used
to uncover c logged arteries around the
heart . Similarly, the ball oon ca theter
used to pos iti on th e fallopo scope in the
fallopian tube - a new tec hnique which
was also eva lu ated in th e FDA stud y 
is muc h lik e the one used with coronary
an giopl asty.
"The new system delivers the
fallop oscope safely into the fallopian
tube by means of a balloon catheter that
unfold s from within it se lf," Williams
ex pl ain s. "T he ba ll oon is actually rolled
within the end of th e cat heter and it
unro ll s from the cathe ter tip , like a
carpe t being unrolled on the floor. Th is
elimin ates any fo rce that mi ght occur
between the balloon a nd the inner wa ll
of the tube."
The unfoldin g balloon, which follow s
the path of the fallopian tube , ha s a
holl ow tube down its middle that allow s
for placement of the falloposcope. When
infl ated, the ba lloon is about the diam
eter of a toothpi ck; the falloposcope that
traverses its midsection is about the size
of a sewing needle.
Willi ams says advancing technology
in the diagnosis an d treatment of
proximal tubal di sease is exciting for
rep roduc ti ve endoc rinologis ts like
him se lf. But what is likel y to have even
greater impact is the potential use of the

"The falloposcope
will allow us to
do anumber of
things we currently
cannot do,"
fallop oscope with assi sted reproductive
procedures, such as GIFT and ZIFT .
Within the next six mo nths, he expects
to begin phase two of the FDA study
which will assess the effectiveness of
the falloposcope in performing
transcervical GIFT. Other investigators
are attempting transcervical GIFT both
blindly or by using ultraso und to guide
them .
GIFT is an assi\ted reprodu ctive
procedure that involves removing eggs
from the female and spe rm from the
male and plac ing th em to gether in th e
fallopian tube. A relat ed procedure,

Z IFT, involves posi tionin g eggs that
already hav e been fertili zed in the
laboratory in th e fallopian tube. At this
time, both GIFT and ZrFT require
surgery usi ng a laparoscope throu gh an
inci sion in the abdome n.
"The falloposc ope would allow us to
directly visualize where we are in the
fallopian tube ," Williams says. "Fertili
za tion norm ally occurs in the third
seg ment (am pulla), so th at 's where we
want to place gametes and embryos.
"Another benefit to this in strument is
that we may be abl e to avoid the cos t of
an operating roo m procedure and use of
ge neral anesthesia. GIFT or ZIFT would
take from IS to 30 minut es as an
outpati ent procedure, and there 's also
th e chance it could even tually be done in
the office."
William s says th e fallopo scope co uld
be valuable when trying to decide
whether to perform GIFT or ZIFT , or
allow the patient to attempt pregnan cy
with her own fallopi an tubes. "If we
have a patient who has had two ectopic
pregn anci es ill one tube and we perfor m
a dye test that indi ca tes her tubes are
ope n, we still need to know the status of
the inner tube. Is there scarrin g, adhe
sion form ati on or decili ation (loss of the
hairs that beat the embryo toward the
uteru s), all of whi ch could impede her
chance at becomin g preg nant ')

Between gloved fingers, the tip of the scope reveals its scale,

The physician 's-eye view through the
falloposcope shows allY blockages
caused by tubal disease,
"O ne way to re so lve this issue i s to
look inside the tubes , and if they ap pear
nor mal, we ca n recommend that the
patient attempt a pregnancy on her own.
W e have a couple of pati ent s in this
situation ri ght now and are awaiting the
outcom e."
Conversely, he says, if a probl em
were discovered inside the fall opi an tube
he could recomm end GIFT or ZIFT to
avo id puttin g the patient through other
procedures that would be unproductive.
"Using th e falloposco pe in assisted
reproductive procedu res i s in th e early
stages and we're on the ground floor, but
I'm optimi stic that the techn ology will
become more refined and evol ve into an
office proc ed ure. Thi s wo uld greatly
ex pand the applicati ons of the
fallop osco pe ."
Some centers in Europe are alread y
usin g the falloposcope to experim ent
with transcervic al GIFT. Willi ams says
at present they are blindl y feeding a
catheter into the fallopian tube or usin g
ultras ound to monitor the catheter 's
whereabouts. Studies in Europe are four
to five months ahead of those in the
United State s beca use governmental
guideline s for human studi es in Europe
are less stringent th an th ose in the
United States, he says.
Williams adds th at the most si gn ifi
cant ri sk with the falloposcope i s tubal
perfo ration, which ca n occur if tin y
wires or ball oo ns are in serted through
the catheter to open clo gged tubes. Such
an occurrence is rare , he says, adding
that at thi s time the in strument is o nl y
used as a diagnosti c too l, not in co njunc
ti o n w ith treatment. •
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RESEARCHERS
EXPLORE WAYS
TO SAVE,
REGENERATE
NERVES

BY JIM KEELEY

T

he neurons in the brain and spinal cord are

unforgiving. Any insult can be catastrophic. A

stroke or back trauma can instantly sever con

nections nature has carefully orchestrated, lead
ing to paralysis or even death. Sometimes, the
insult is insidious, as when the body succumbs to
old age or disease and produces less of the nutri
tive proteins that bathe and feed the nerve cells
that cluster in the brain and spinal cord. Without
a source of nourishment, those neurons stop talk
ing to each other, wither and die. This may be
what happens in degenerati ve conditions such as
Parkinson's and Lou Gehrig's disease.
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William D. Snider, M.D., investigates proteins called neurotrophic factors that nourish nerve cells, may save them from death
and even initiate their regeneration.

De sp ite concerted effort and the
appli cati on of mo lecular bi ology ,
neuro bio log ists have not fou nd a
" Lazarus fa ctor," a dru g that saves
neurons from death or initiates rege nera
ti on. The proble m ha s bee n that th e
ne rve connec tions lead ing from mu scl es
to th e sp in al cord a nd then to the brain
are so com plex th at th ey de fy under
stan ding. Onl y improved know ledge of
th e nervou s sys te m can po int to the
dru gs that will rest ore wrec ked neuron s
and shattered synapses.
Alth oug h sponta neous ne uro nal
regen eration occ urs in lowe r speci es, it ' s
not li ke ly that human ne urons can ful ly
recove r from se rious inj ury or dege nera
ti ve disease by them se lves . Help mu st
co me from researc hers reachin g int o th e
nervous sys te m an d plu c kin g out
protein s th at may be of use. And
sci enti sts are j ust now warming up to
th at c hal len ge, ha vin g iso late d about 20
neu ronal prote ins that ca n resc ue ce lls

from dea th , rev erse degenerati on and in
some cases initi ate regrowt h.
The first of the prote ins, called
neurotro phic fac tors (th e Greek I rop/lI?
mea ns nourishment ), is now bein g tested
at the Sc hool of Medic ine on people
with Lou Gehri g's disease (amyotrophic
latera l sc leros is). And more trial s of
th ese drugs are ex pected so on for othe r
diseases.

RIVERS OF GROWTH
In the neurobiol ogy co mmunity 
wh ere the ba sic sc ience of these protein s
is worked out - bench sc ientists
looki ng for c lues to how ne rve connec 
ti ons are fo rged and nourished are
commu nica tin g with c linici ans trea ting
brain and spinal cord damage . That
commu nication , both groups say, is th e
key to understanding nerve re pair and
how to remedy ailment s of the brain and
nervous sy stem.

Accordin g to William D . Snider,
M.D., ass ociate professo r of neurology ,
regenerati on of nerve processes in the
ce ntral ne rvo us sy ste m occurs poorly if
at all. " Ri ght now we can onl y get
extre me ly limited regenerati on in lab
models, " Snider says . " We think of
re ge ne rati on as more of a long-term
goa l." Bu t Snider and other neuro bi o lo
gists at th e Sch oo l of Medicin e belie ve
that if th ey can und erstand how nerve
connec tions are fo rmed durin g devel op
ment and the n maintain ed, th ey ca n
make great prog ress in disc overin g how
the bod y mi ght naturall y mend bad
co nnecti ons. "Thi s is more th an just
intere stin g de ve lopme ntal neu ro bi ol
ogy ," Sn ider says. "In order fo r us to
approac h neural injury, we have to
und erstand what makes nerves grow."
Scattered on the sur faces of Sn ide r's
office are hundreds of slides paint ed in
neon red, elec tric ye ll ow and vibra nt
green hu es . Unde r th e mic rosco pe , the
13
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slides reveal river~ of co lo r twisting and
branching. These riv ers are actually
neurons injected with a dy e that traces
th e course taken by neuro nal processes
as th ey snake th eir way to the rat spinal
cord. Each slide is a map that allows
Snider to follow th e deve lop ment of
sp inal cord circuits .
The dye, Dil (pro no unced die-eye ), is
a godsend for ne urobiology, Snider says.
Without its brilliant color and ability to
stain neurons and th e ir axons - the part
that projects away from th e cell body 
deve lopmental neurob io log ists would
not ha ve the maps they need to study the
formation of ne rve connections. Each

SNIDER IS TESTING THE THEORY
THAT GROWTH FACTORS GUIDE GROWING
NEURONS TO THEIR TARGETS.

slid e te ll.s Snider a littl e bit more about
the creat ion of the nerve netwo rk that
allows the brain, spinal cord anel limbs
to work together to se nse pain, heat and
pressu re. Although his bench work is a
long way from the neuromuscular
degeneration Snide r sees in the clinic ,

Neurons injected with orange dye make a clear map of their paths as their processes
grow toward their targets, dyed green in this photo,
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the resea rc h familiari zes him with
ne uro trophic factors that could be
tomorrow's medicines.
A theory that Snider is testi ng is that
growth factors guide growin g neurons to
th ei r targets. Scientists know that as a
neuron grows it sends out an axon, a
lo ng projection that grows to a target.
But it is still not known what ca uses an
axon to ho me in on a spec ific ne uron or
a precise de stination in th e sp in al cord.
Snider believes that growth factors play
a key role in this process. He theorizes
that as the axon extend s away from the
ce lJ body it may "fee l" it s way to its
target by g rowing along a c he mi ca l
path way of neurotrop hic factors sec reted
by the targe t cell. It 's as if eac h ne uron
has a built-in homin g device th at locks
on to a gro wth fa ctor prod uced by the
t'lI·ge t it is supposed to reac h. Once the
target is reached , Snid er hypothes izes
that growth factors agai n exe rt control in
es tablishing the compl ex circuitry
necessa ry for normal nervous system
function. An y di sruption in the flow of
growth factors to the developing neuron
ca n be chaotic; ne uro ns stop g ro win g,
retract their processes and die.
Snider recently demo nstrated just
how import a nt ne urot rophic factor s are
to specific popul ati o ns of developin g
neurons in a report in the journal
Neuron. Th e report show s that wh en
dorsal roo t gang li on ne urons - th ose
neuron s that relay information fro m
limbs to th e spin a.! cord - are de pri ved
of nerve g rowth factor ( GF), they fai I
to reach th eir target in the spinal cord
and die. An antibody to GF inj ected
into embry o ni c rats shuts off the flow of
NGF at a cruci al tim e. The investi ga 
tions show that NGF deprivation causes
a dram atic drop in th e number of the
particul ar types of neurons that se nse
pain and te mperature.

I'JI

The research reported in Neuron
shows that the absence of a specific
neurotrophic molecule can affect the
survival of a single type of neuron.
Furthermore, the results suggest that
antibodies to NGF could be used to
block pain sensations by interfering with
nerves that project to the spinal cord,
Snider adds.

I

l1

11

NOURISHING NEURONS
The recent identification of neuronal
growth factor s has opened up a new area
of research for neurobiologist s. Scien
tists now can approach rationally the
specific effects of a neurotrophic factor
on a given type of neuron. Because there
are more than 20 different nerve growth
factors, and surely more to be found ,
researchers must understand their effects
before they can approach clinical
studies.
So far, the NGF family consists of
three closely related growth factors:
nerve growth factor, brain-derived
neurotrophic factor (BDNF), and
neurotrophin -3 (NT-3). Snider believes
it's poss i ble that each member of the
NGF family is responsible for the
survival of a different set of neurons.
" When all we had was NGF, we were
limited in our studies. Now that we have
these other growth factors, we should be
able to learn more about how the
peri pheral nervous system is estab
lished," he says, about how nerve
growth is nouri shed and guided.
ft 's been 40 years since Rita Levi
Montalcini isolated the first
neurotrophic factor, NGF, in her lab at
Washington University. Scientists
immediately recogni zed that it might be
possible to use NGF to push human
nerve cells to repair themsel ves. In
theory, nerve growth factors could be
gi ven to pati ents whose own bodies had

Dil, the dye that stains neurons, is placed along the back of a laboratory animal.
The dye will travel to the spinal cord along the axons of sensory nerve cells.

stopped supplying them. Forty years
later, the journey from theory to practice
is still not complete. Researchers have
found that getting growth from neurons
in culture is a lot easier than prompting
damaged nerves with growth factors in

vivo.
Snider's developmental work is all
the more important now that clinical
trials of neurotrophic factors have
begun . The more scienti sts can learn
about how cells depend on specific
factors for survival, the closer clinicians
will be to presc ribing appropriate nerve
growth factors for diseases like Lou
Gehrig's, Parkinson's, Al zheimer's and
peripheral neuropathy. Understanding
how the body naturally promotes and
stabilizes the formation of nerve
connections could lead to a "recipe" of
growth factors for healing nerve cell
damage.

" I N ORDER FOR US TO APPROACH
NEURAL INJURY , WE HAVE TO UNDERSTAND
WHAT MAKES NERVES GROW. "

There has yet to be a successful
clinical trial of a neurotrophic drug, but
optimism for these promising proteins is
strong. Lately , research in thi s field has
undergone its own regeneration. Biotech
companies with hopeful- so unding names
like Neurogen and Regeneron are
supporting neuroscience research ,
hoping for a big payoff when
neurotrophic drugs finally become
clinically applicable. These companies
and mill ions of Americans hope that
protein s pulled from human nerve cells
can rejuvenate sick neurons.
During development, neurotrophic
factors are capable of marvelous feats.
Why shouldn't they be able to help
with motor neuron disease or
Alzheimer' s? Snider is optimistic that
human trials of neurotrophic drugs will
succeed, becau se he has watched these
proteins form neuronal connections from
scratch and remodel them if necess ary.
"If these first trials succeed - and it's
my belief that they will - then you'll
see an explosion in the number of
neurotrophic drugs coming into the
clinic," he says . •

15

•

by Juli Leistner

Severe Psoriasis Can't Be Cured,
But It Can Be Treated

~16_ _ _ _ _ _ _ _ _ _ _ _ _ __ __ __ __ __ _~~~_ __ _ _ _~L

T

he disease was winning. Afler 11
years of Irealing her psoriasis by
herself. Nancy Neumann realized
Ihal she needed help. Whal had begun as
a mild case of red, patchy scales on her
legs gradually gave way to fast-growing,
thick plaques all over her body. They
flaked, itched, hun and sometimes
cracked and bled. At work, Ihe 17-year
old nurse applied IOlions to remain
comfortable enough to finish the day.
Her YMCA asked her to SLOp using the
swimming pool. A cashier refused to
take money from her hand.
To regain the upper hand, Neumann
turned to the School of Medicine ' s new
Barnes West Dermatology Center for a
carefully administered, whole-body
treatment of tar and artificial light.
Psoriasis is a chronic , incurable skin
disease that affects about one in SO
Americans, or 4 million people. It
usually appears bet ween ages 20 and SO .
Although its cause is unknown , medical
research tells us it stems from an
overgrowth of skin cells. In its mild
form , red scales typically develop on the
elbows, knees and scalp. Outbreaks
occur spontaneously or can be triggered
by stress. bacteria or any trauma to the
skin such as insect bites or shaving. In
severe cases. scales develop inlO
persistent, thick plaques that cover from
13 to 100 percent of the body's surface.
Neumann. one of the center's first
patients, originally treated her psoriasis
with over-the-counter medicated creams.
Then about two years ago. the disease
progressed to involve nearly her entire
body surface. ,·It gOI 10 the point where
it was uncomfortable as well as disfigur
ing. It was really interfering wilh my
life," she says. Last fall, she sought help
from a dermatologist. bUI his news was
not encouraging: Six to eight months of
treatment with ultraviolet B (UYB) light
- the sun's tanning rays - would give
her improvement but not remission.
Then she was introduced to the school's
dermatology cenler through her psoriasis
support group, a local branch of the
National Psoriasis Foundation.

In the Goeckermallll method (~f treatillg
severe psoriasis, patiellts receive
cOlltrolled exposure to ultraviolet B
light ill a light booth.
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The red scales characteristic ofpsoriasis are visible in photograph A. III B, a nurse carefully applies sticky, pungent tar
medicated with salicylic acid. In Photo C, the treatment continues with the application of commoll plastic wrap. Photo
graph D, that ofa different psoriasis patient's arm, reveals the success of the technique.

The center's tar therapy, caJJed the
Goeekermann method , is not new; the
fac il ity' s hall mark is that it offers the
Goeckermann therapy on an outpatient
basis. Traditionally patients have
received the treatment in threc- to six
week hospital stays. But for the past five
years or so. insurance companies have
been reluctant to pay for the costly
inpatient care. In 1987, Arthur Eisen.
M.D., head of the dermatology division,
and Ann Martin, M.D ., assistant profes
sor of medicine in dermatology, antici
pated a problem and began looking for
alternatives.
"Insurance companies were turning
down psoriasis patients who really
needed something more extensive than
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just seeing their doctor every three
weeks. We were concerned about what
we would do for these patients if it
really came to be the case that they
could not be hospitalized ," Martin says.
The center opened in March, one of
only 30 of its kind in the country a nd
eight in the midwest. It gives patient s
more convenient care for about one
fourth to one-third the cost of inpatient
care.
"This new center provides a very
good alternative to hospital care without
compromising effectiveness," says
Karen Forsman, M.D., director of the
center and instructor of medicine in the
dermatology divi s ion. She and her staff
treat patients with psoriasis on at least

one-fourth of their bodies; psorias is on
36 percent of the body would cover the
entire trunk and buttocks.
Neumann drove one hour each day
from her home in Imperial, MO, to be
treated. "When I started treatment, I had
psoriasi s on the palms of my hands, on
the bottoms of my feet, on my legs, my
arms, my abdomen, my chest, my back ,
in my hair, inside my ears. There wasn't
an area of my body that wasn't affected
in some way," s he says.
Patients receive a six-hour treatment
each day, five days a week, for a total of
IS to 18 treatments . An initial exam by
Forsman determines the amount of light
and the strength of the tar needed. Then
patients step into a light booth for

anywhere from 12 seconds to 12
minutes. Next. Illlr;,eS use tongue
de pressors to swab on a sticky, pungent
layer of tar over the patient's entire
hody . The tar is medicated with salicylic
acid that rellloves the scales. Nurses
must be carefuJ to apply the tar in the
direction of hair growth; brushing the
other direction can inflame hair follicles.
Some patients an: also wrapped in
plastic wrap , which maximizes the tar's
effect by increasing its pe ne tration into
the skin. A tar shampoo goes on the
pati e nt ' s head and is topped off with a
shower cap. Then the patient slips into a
scruh suit and bides time for four hours .
Arter lunch, patients remove the tar
by soaking for 15 minutes in a warm
bath dosed with mine ral oil. Several
careful cl ea nings remove the shampoo.
Next they return to Forsman. She
prescribes another dose of light followed
by the second layer or tar. Pati e nts put
c lothing on over the tar - Neumann
invested in tw o black swcat suits - and
drive home .
At ho me, the patients leave th e tar on
for a few more hours , shower it ofr,
apply a third coat and sleep in it. "Then
you get up in the morning, shower it off
and start all over again," Neumann says.
Throughout the treatment , patients must
resist the temptation to rub their skin;
trauma from scruhbing. combs or
fingern ails ca n agg ravate psoriasi s.
The Goeckermann method was
developed in the 1920s at the Mayo
Clinic in Rocheste r, MN. It has re
mained one of the safest and l1lost
effective psoriasis treatments available ,
Forsman says, although prec iscl y what
mechanism the treatment uses to arrive
at its effectiveness is not yet clear. The
other possible treatments - including a
medication called etretinate. the anti
cancer drug methotrexate. and PUV A
therapy, which uscs light in combination
with thc drug psoral e n - carry side
effccts, can become toxic and require
close monitoring hy a physician, she
explains.
Although the Goeckermann method
does not cure psoriasis, it usually
produces a temporary remission; patients
must repeat the therapy fro m time to

Nallcy Neumann was one of the first to
receive psoriasis treatmellt on all
outpatiellt basis from the medical
school's new dermatology cellter.
Pleased with the results, she continues
follow-up light treatmellts.

Karen Forsman, M.D., directs the care
ofpatients with severe psoriasis.

time. Studies show that by the end of the
treatment, the majority of patients are
free of plaques; 90 percent are still clear
eight months later, and 73 percent are
clear after one year, Forsman says.
Neumann was delighted with her
results. Her skin was clear except for
sca ling on her nails and in her ears and a
bit of redness where plaques had been .
Now , weeks later. the rednes s is nearly
go ne, and she continues with follow-up
light treatments. ·'It's been the best thing
that could have happened to me. It was a
very positive and rewarding experience
for me to get treatment and have it be
the success that it was," she says.
Cases of psoriasis have been docu
mented for 2,600 years, but its cause and
cure remain undiscovered . Researchers
suspect a genetic and immunologic
origin; roughly one-third of psori as is
sufferers have a family member with the
disease. Forsman says. The inflamma
tion that comes with psoriasis could be
due to the high levels of white blood
edls. interleukin-6 and arachidonic ac id
found in psoriat ic skin, she adds.
Various growth factors and pol ya mines
- chemicals important in cell reproduc
tion - are also abundant in psor iati c
skin and may lead to the excess cell
growth. And plaques seem to develop or
worsen with streptococcal and yeast
infections, Forsm an says.
The need to understand and control
the disease goes far beyond cosmetic
concern s; severe pso ria sis can be life
threatening, stresses Martin. "When skin
is diseased, all of the fun ctions it
perform s break down," she says.
Psoriasis interferes with the skin's roJe
in controllin g body temperature and
providing protect ion from infection and
dehydration . In add ition to the physical
toll, the disease can lead to feelings of
shame and anx iety that can interfere
with social activities.
But Neumann urges psoriasis suffer
ers not to be ashamed of their disease .
"People with psorias is should learn to
try to control the di sease and not let it
control them. Because they are going to
have to deal with it for the rest of their
live s." •
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cientists and artists both use
the word "study," usually
with very different mean~
ings. As the cover photograph
of this issue makes plain, their
two defini tions sometimes
converge.
Exploring the development
and behavior of the hugely
complex nervous system, neuro
scientists record images of their
observations and manipula
tions. Investigations go on at
that essential level where neu
ron communicates to neuron
through electrochemical junc
tion, where nerve meets muscle,
where receptors organize to
receive information coded in
chemical neurotransmitters.
Collectively, these are the
operations and the messages
and the junctions that define
life. So it is no surprise that the
scientific images beat with a
vitality that lifts them out of
the informational and into the
aesthetic. In this pictorial,
Outlook presents a few of the
visions that inform the neuro
scientist and may inspire us all.

!

S

l' A snake's living muscle fiber is
shown in blue-green; the nerve that
innervates it is in orange and red. The
axon can be seen leading to its target,
and the individual button-like dots on
the muscle are the synaptic "boutons"
of the nerve end. Boutons possess two
compartments - shown separately in
yellow and red. The yellow stains the
compartment that houses mitochon
dria; the red highlights the compart
ment containing the neurotransmitter
that the boutons release.
From the laboratories of Jeff W . Lichtman,
M.D . ,Ph.D . , and Robert Wilkinson, Ph.D.
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~Reaching

out to other neurons, a
healthy mouse nerve cell in culture is
stained to show the structure of its
processes. The irregularities near the
ends of the spindly neurites are called
spines and are the sites at which nerve
to-nerve communication occurs.
.F rom the laboratory of Mark P. Goldberg,
M.D., and Michael Bateman.

I·
:t

+-The large, striated structure here is a
single mouse muscle fiber. The brown
element is a neuromuscular junction,
or synapse, the site at which nerve
communicates with muscle. And the
blue "dots" are cell nuclei. Their
bright color is an indication that
elements in the gene for a neurotrans
mitter receptor are being expressed
principally here. The upshot is that
muscle cell nuclei at the synapse are
different from others; their expression
of chemical receptors is one clue
nerves may use to find their way to
appropriate targets.
From th e laboratories of Joshua Sanes, Ph.D.,
and John P . Merlie, Ph.D.

21

+-Nerve cells are shown at high
magnification in a living slice of rat
brain. The cell bodies and their
processes - axons and dendrites - are
visible and can be observed as the
nervous system matures. If the cells
continue to behave as they would in
the brain, observing them will instruct
researchers about how the nervous
system develops.
From th e laboratory of Robert Wilkinson, Ph.D.

-+A stained slice of rat brain at low
magnification shows the same "swirl"
arrangement of neurons revealed by
the arc pattern of the previous photo
graph. Here, individual nerve-cell
bodies are visible, but their processes
are not marked by the stain. In hu
mans, this region of the brain, the
hippocampus, is called the "seat of the
sou!." Closely connected to memory
function, it is an area of the brain
particularly susceptible to stroke.

1

1

From th e laboratory of Robert Wilkinson , Ph.D.

)

+-Pseudocolor defines the density of
receptors on the membrane of a muscle
fiber in a living mouse. The receptors
are for acetykholine, the neurotrans
mitter at the neuromuscular junction.
During development, muscle fibers are
at first innervated by more than one
nerve. Subsequently, they undergo a
change that leaves each muscle fiber
innervated by only one nerve. As
competing nerves are eliminated, the
density of receptors on- the muscle fiber
beneath the losing input drops. In
these two images, taken 17 hours
apart, receptors disappear, as shown by
the smaller peaks visible in the lower
left.
From Rita Balice-Gordon Ph.D., and leffW.
Lichtman, M.D., Ph .D.
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-+Plaques and tangles invade the brain
of an Alzheimer's patient. The larger
plaques lie outside of cells and are
deposits of beta amyloid protein that is
thought to be toxic to nerve cells. The
smaller, denser tangles are filaments
within the nerve cells that have been
damaged by the disease process.
FTOm the laburatury of Jos ep h L. Price, Ph.D.

'" Nerves compete with one another to
innervate muscles. The battle is visible
here between green- and red-stained
nerves. Each picture is of different
nerves and different muscles. Two
nerves progress from being nearly
equal at embryonic day 17 until one
has become established and the other is
in retreat by post-natal day lOin the
mouse.
From Rita Batice·Gordon Ph.D., and Jeff W.
Lichtmun , M.D.,Ph.D.

'" Blood vessels are shown in the brain
of a mouse just before birth. Research
ers believe the hairlike structures,
called filopodia, join to form a continu
ous channel that supplies nutrients to
the brain.
From Car! Rovainen , Ph.D. and Thomas A.
Woolsey, Ph.D.
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Student Stag
Wrest iJ g With Igno.-al ee

-------

b\'. Chenl
. S. Rucker
ike most medi cal
stud ents, I ap
proac hed my th ird
year with so me trepidati o n. I
had heard horro r stories fro m
bl ac k students about recei v
in g bot h blatant and subtle
rac ist attacks o n the wa rds
and be in g un able to res po nd
or address the issue, Su ch
sto ries made me anxi ous, bu t
I re me mbered my hi gh
sc hoo l band direc tor's teach
in g, " Behind e ve ry pro blem
lies an o ppo rtunity."
I so li ci ted the opini ons o f
several bl ac k fo urth- year
students unt il I fo und som e
one who had had mos tly
good experie nces an d as ked
her how she approached th e
third year, A positi ve atti 
tude, sel f-co nfidence , consis
te nt readin g and preparati o n
were the keys, she said. But
she ag reed with oth e r stu
dent s ' advice - don' t look
for rac ist sli ghts, and if th ey
happen , do n' t bl ow your top .
In other word s, don't ri sk
getting a bad eva luat ion. The
awareness that third -year
e valu ati ons were large ly sub
jective and the th ough t that I
could be poorly evalu ated
becau se of one person 's
prejudi ce sca red me a nd iso
lated me from my mos tly
w hite c lass mates, eve n as
early as the end of seco nd
ye ar, be fore spending eve n a
da y on th e ward s.
I believ e that pos iti ve in 
ne r thoughts do attract po si
ti ve da i Iy experi e nces.

L
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Reso lved to ma intain a pos i
tive attitude, I do nn ed my
freshly starched white j ac ket
and stu ffe d it with my ne w
stethosco pe, spiral manu a ls
and name tag. Although it
was diffi c ult to bel iev e that I
actu a ll y knew any thing, I
soo n de veloped a co mfo rt-

~~LL\S

that way . He re pl ied, 'T II
bet when yo u' re around
blac k friend s, yo u use a
bl ac k dia lect. " Calml y, I pro
ceeded to tell him th at a ll
blac ks are n't the sa me and
do not ta lk the same. ,I th en
po inted out tha t his exposu re
to blac k peopl e had obvi

ahlack feulule physit'ian~

I rraliz{ that tlu·s(·little struggles
\\111 he an everyday part of Illy
tne(lical career. ,

able rh ythm . My internal
medi c ine tea m was very ca
sua l, and we ofte n sa t in at
te ndi ng round s hav ing li vely
debates abo ut curre nt iss ues.
On e day a team mem ber
remarked, "Cheryl, you
do n't ha ve a Southe rn acce nt
like most peo ple fro m the
So uth." Thi s la unc hed a con
versatio n about te le vi sio n
personalities who drop the ir
accent s in order to co mpete
in that job marke t. Anoth er
stude nt matter-of-fac tly re
marked that Bryan t Gumbel
"did n't ta lk like th e bl ac k
men he grew up with ," I re
mind ed him that he worked
with me and th at 1 didn ' t ta lk

o usly bee n limited, s ince he
thought a ll bl ac ks speak in
slang and curse word s. The
atte ndin g saw the conversa 
ti o n becoming a little terse
and gracefull y c hanged the
topi c.
Although I had gone
aga inst an upperclas s
wo man 's advi ce and con
fronted what I considered a
rac ist remark , I fe lt good
abo ut it. From th at day on,
th e attending seem ed mo re
interested in and suppo rti ve
of me as a stude nt. and he
re mains my ad viso r and
mento r. Th e o ther student
neve r made comm ent s like
that aga in, and altho ug h we

co nti nue d to get al ong 
perh aps e ve n better - I re
tained a fee lin g th at I co uld
not tru st him .
My first surgica l experi 
e nce was initiall y sca ry, but I
fe lt protected by the blac k
scrub nurses in the gyneco
logic o pe ratin g room. Th ey
wo uld ma ke sure I had
breakfas t so th at I wouldn ' t
fain t during su rge ry, hand
me inst ruments before I
could as k, and willingly g ive
me info rm ation about whi c h
attendings lik ed and di sliked
students. As [ moved o n to
ge neral surge ry, I noticed a
c hange in the c li mate . The
whi te sc rub nurses we re of
te n bru sq ue and terse with
me comp ared to th e way
they treated my white, male
counterpa rts. Fo r ex ampl e,
whe n the nurses bro ug ht in
stools for the o th er "s tude nt
doctors" to sit o n durin g sur
ge ry, 1 was ine vitab ly ne
glected until my res id e nt
remind ed the m that I needed
one as well.
On the last night of a sur
gery rotation , the res ident
and I prepared to ha ndl e our
last case. As we were wa it
ing for the anesthes iolog ist
to get ready for the case, 1
hun g around eagerl y await
ing th e read y signal that the
pati e nt would be bro ught
into th e ope ratin g roo m and
preparati on for surge ry
would beg in. Soon, one of
the nurses signall ed that th e
O R was ready and called for

r,
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Medical stlldellt Cheryl S. Rucker

the doctor . 1 replied, " I cou ld
start gelling the patient
prepped and draped." She
looked at me with disdain
and yelled after me as I
walked down the hall. " Nol J
need a doctor, you're not
good e nough."
I struggled to hold back
th e tea rs. The circulating

nurse apo logizecl for the
other ' s comment. It was
meant to hurt and it did , but T
refused to let it show. My
resident ancl I prepared th e
patient for surgery and we
completed the case without
incident. T managed to fee l a
sense of accomplishment
despit e the ear li er disparag -

Ing comments of the nurse.
r was not alone when it
carne to degrading experi
ences. A black female class
mate was completing her
patient's physical exam and
emerged from behind the
curtain wearing her white
coat. a stethoscope around
her neck, her ENT kit in

hand, notebooks in her pock
ets, and a c1i pboard filled
with journa l artic le s. As she
made her way to the door ,
the patient 's roommate , after
licking his fingers, said to
her, "Ma'am , did you make
this ch icken? It sure is
good l" She replied. " No, sir,
I didn ' t." She fumed silently
for hours, but when she told
me about it, T sm il ed , then
laug hed. We rea li zed It
didn ' t help to get angry ev
ery time others assumed we
were cooks, clerks, janitors.
or nurses .
I tri ed to conso le myself
and my fri e nd; maybe com
men ts like th at aren't racial.
Maybe the sc rub nurse
would have said that to any
studen t; maybe that man
would have sa id that to any
woman. Black s in the profes
sional world deal daily with
a constant lack of recogni
tion and respect for the ir ac
complishments. As a black
female ph ys ician, I rea li ze
that the se littl e strugg les wi ll
be an everyclay part of my
med ica l ca ree r, and that r
will constantly wrestle with
ste reotype s. My triumph is in
ris ing above them and mov
ing on to educate others.
Rl.'I)rilltcd 1I 'l 'li per,,/;.nioJ7 li"oll/

Journal of Ih e America n M ed i
cal Assucialion (JAMA). M ill' 6.
1')92: Volullie 267. NlIIllh er 17.
C()flYriglli 1992, Allierica/1 Medic(/I
lilt

A.Lwnialioli . •
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Silhouette
hltoT e
bv Kleila Carlso/1
hat David M Kipnis,
M.D ., ca n see into the
future no longer sur
prises those who work with
him , They have witnessed
his visio n beco me reality at
the School of Med icine ,
Stepping down from hi s
administrative duti es afte r
two decades guidin g the De
partm ent of internal Med i
cine, Kipni s elevated the
depanme nt to world promi
nence . He attrac ted soug ht
afte r scie ntific minds , forged
new ave nues of sec uring re
sources and brid ged th e div i
sion between bas ic and
clinical sc ie nces.
Washington University
Chancellor William H.
Danforth says of him,
" Washington Uni ve rsit y
School of Med icine would
be a different and much
lesser instituti on without
David Kipni s. He has scien
tific understanding and vi
sion and a gi ft for putting the
right peopl e in the right
places. Hi s dee p affection
for this in stitu tio n and his
exa mple of co mmitm en t,
acco mplishment and dedica
tion ha s in spired LIS all to
greater heights."
Kipni s came to Wa shin g
ton Un iversity in 1955 as an
American College of Ph ys i
c ian s Rc ~ cal'ch Fellow to
study under Nobe l laureate
Cal'l F. Cori , M. D., and to
pursUl.' hi s own r 'search in
dia bete s and endocrinology .

T
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His work ha s been cited for
many honors, in c ludin g the
Endoc rine Society's Ern est
Oppe nh eime r Award and th e
American Diabetes Assoc
iation's Lill y Award.
Researc h remains his first
love , but hi s pos ition as an
adm ini st rator has preven ted
hi m from being as acti ve in
it as he wou ld like. Still , he
says , skill s tha t are appl i
ca ble to scientific resea rch
do not go to was te in admin
is tration.
"1 would say about 80
percen t of my time is spe nt
with administration, but th e
administration inv olves find
ing sci entific tale nt , develop
ing res ources (laboratory
space . equipment and fina n
cial support) that make it
attracti ve for you ng peopl e
to come here , working with
hos pital administrators to
develop strategies in a mar
ket -orie nted health care sys 
tem and sustaining a viab le
enterprise fo r the medical
school and hos pitals," says
Kipnis .
Kipni s, whom Danfort h
ca ll s a "genius for fina nce,"
has been a creative devel
o per of I'eso urces that are
incre as in g ly difficult to
come by. The Wash ington
University/ Monsanto Bio
medical Researc h Agreeme nt
- the largest research co l
laboration between an
American company and an
American uni vers ity - was
eng ineered by Kipni s and the
late Howard A.

Schneiderman , former sen ior vi ce president for re
search and develo pment and
c hief scientist at Monsanto.
Th e ag reement, fir st reac hed
in 1982, c urrently ex te nd s
through 1994. It amounts to
nea rly $ 100 million in re
search funding and su pports
50 research projects involv
ing 120 uni ve rsity sc ie ntist s.
It is one example among
many.
Kipnis' business acumen
ha s benefit ed hi s departm e nt
as well as the sc hoo l. The
number of full-time fac ulty
ha s increased ne arly fo ur
fold, from 46 to 160, in clud
ing 110 ph ys icians at Barnes
Hospi tal, 38 at Jewish Hos 
pital , and between 12 and 14
at the John Cochran
Veteran's Admini strati on
Hosp ital. The department' s
tota l ope ratin g budget, which
20 years ago was $4.5 milI ion , now approaches $110
million and accounts for 25
perce nt of th e total research
budget for all of Washing
ton University.
Th e spectrum of research
now ranges from the most
fundam e nt al scie nc e to the
most clinical app li ed re
searc h. Kipnis was respon
sib le fo r broadenin g researc h
hori zons because he believes
interact ion between the bas ic
and clinical sc iences is "es
sential to th e in te llec tual vi
abilit y of the Depa rtm ent of
Medi cine,"
" With out the ba sic sci 
e nces and th at kind of cl os e,

co llaborativ e int eract ion, we
wo uld not be at the c uttin g
edge that we are now," says
Kipni s. He notes that more
than half of th e fac ulty in the
departme nt of medicine ha ve
joint appointments in basic
sc ie nce departments.
Longtime coll eag ue and
fri e nd Cad Friede n, Ph .D.,
professor of biochemistry
and molecu lar biophysics,
says Kipni s' greates t accom
plishment was laying th e
foundation for the coope ra
tive spirit that exists between
basic science and c lini ca l
medi ci ne. "When he arriv ed
there were a lot of people
here who influenced his feel
ings about bas ic science and
the importance of basic sci
ence to c li nic al work," says
Frieden. " People like Arthur
Kornbel'g and his associates,
Paul Berg, Melvin Cohn,
Dale Kaiser, Davi d Hog ness
and others. J don't think
th ere's any better de part me nt
of medicine anywhere be 
calise th ere are so man y
peopl e here who are doing
good basic sc ience . Dav id
has a real eye for se lecti ng
peop le who are able to do
basic scie nce and carry out
ba sic resea rch in a clinic al
settin g, and that distin
gui shes the departme nt from
all others."
Kipnis says both branches
of med ic in e have benefited
from thi s bil a teral influ ence ,
which is ev idenced in the
success of young sc ientists
suc h as Jeff Gordon, M.D. ,

David M. Kipnis, M.D.

who last year was named
alumni professor and head of
the Department of Mol ecu lar
Bi o logy and Pharmacol ogy.
"David has a unique gift
for being ab le to see the
world through other people ' s
eyes and ye t not feel the
need to impose hi s ' rea lit y'
upon them," says Gordon.
" He has been able to us e that
talent to describe and create
niches for young people JI1
hi s department that allow
them to evolve and develop
in a way that is most mean
ingful to th e m, yet at the
same time is conducive to
their development of a feel
ing of competence. These
things were possible because

David derives great personal
pleasure in the success of
young people. For students
and young faculty alike , the
process of science is rea ll y a
jo urney of se lf-di scovery; T
think that David gave many
of us the courage to emba rk
on the journey."
Kipnis says, "When you
see that (success) happen,
it's almost like being a par
en t. Tt's tremendou sly grati
fying. Tn my own career, I
was aware that the key
people - people like Carl
Cori - see med to enjoy my
success. I think he took grea t
satisfaction and pride in my
success, and I've had th e
same feelings for many

members of this depart
ment. "
That success breed s suc
cess is apparent in the De
partment of Medi cine, one of
only two in the coun try that
boast four mem bers of the
National Academy of Sci
ences. In addition, Kipnis
says the department has im
pressive representation in the
Association of Am erican
Physicians and the American
Society of Clinical Tn vest i
ga tion .
Kipnis is as proud of the
department's young sc ien 
tists who are nomin ated fo r
and win fellowships and
awa rds, such as those from
Burroughs Wellcom e, Mar

key, Pfizer. Culpeper and
American Heart Association.
"David is especially dedi 
cated to the talented young
and he has the unique ability
to creatively develop re
so urce s to allow young.
pe opl e to fulfill their poten
tial," say s William A. Peck ,
M.D ., vice c hancellor for
med ica l affairs and dean of
the medical sc hool. "He is
recogni zed worldwide as a
brilliant analyst and advisor
and is perceptive of situa
tions; he alw ays seems to
know what to do and how to
do it at the right time. "
As for the future, Kipnis
says the greatest c hallenge
facing the uni ve rsity is to
develop an attitude of trust
in its young. He believes
those wh o are ultimately re
sponsibl e for the fiscal and
administrative operatio n of
the in stituti on must co ntinue
a path of aggressive invest
ment and tru st in the faculty,
and in turn th at the faculty
has a responsib lity to per
form for th at investment.
"Education and new
knowledge are exciting, and
I think the administrative
structure has to have an ex
citement and perceive itself
as a servant rather than a di
rector," he says. "The faculty
also has a major respons ibil 
ity. I think that se lf-content
ment is a deat h knell; no
matter how good you are,
you can alway s be better. [
think that med ioc rity shou ld
not be tolerated , at any level.
And tenure, which J firmly
believe in , is no excuse for
maintaining or tolerating me
diocrity. The relationship
that exists between faculty
and administration sho uld be
one that sustain s real loya l
ties and affection."
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The Alumni Be ort
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Tak~s

AlUJ1Ull

r\S~()(·jalioll ~s

Rt.. ill, .
enelope G.
Shackelford. M.D .
'68, assumed the
presidency of the Was hing
ton University Medical Cen
ter Alumni Association
(WUM CA A) on Ju ly I.
1992. Shackelford, whose

Penelope G. Shackelfortl,
M.D.
specialty is pediatric infec
ti o us disea 'es and specifi
cally the de ve lopmen t of the
immu ne syste m, completed a
one -year interns hip at ase
Wes tem Reserve afte r he r
graduati on , then returned 10
Wa~h i ngton Unive r~ity

Medical Center for he r resi 
de ncy in pediatrics an d a fel
lowship in infect ious
di seases . Today, she wo rks
o n an tibodies to bacterial
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polysaccharide s, the coat
that allows bacteria to evade
the body's defenses.
S hackel ford says she
hopes to lead the alumni as
sociation in the theme that
ha s been establ is hed over the
last few years, seeking ways
in which alumni can s upport
current students. S he sees
three areas of effecti veness
for alumni: recruiting stu
dents , furthering student ex
posure to clinical medicine
in real-life settings and ad
vising them in their career
choi ces.
"Changes in the ways in
which healthcare is delivered
have made it harder for stu
de nts to get full exrosure to
cl inical medicine." she says .
"We 're high ly specia lized
and often see onl y very com
plicated cas s." In res ponse
to tha t tr nd , she fo r ee: a
program in which students
might spend time in the
clinical offices of alumni,
experiencing precisely what
the more general practice of
pediatrics or interna l medi
cine, fo r ex ample, is like. A
network of alumni outs ide
the exi ~ti ng faculty coul d
he lp provide that exposure,
she says.
In addition . S hac kelford
hopes to comin ue the alumn i
association 's <; upport of stu 
d e nt volun tee r programs
such as ST ATS ( tude nts
Teach ing AIDS To Stu
den ts ), the dru g education
progra m and the Young Sc i
enl ist Program.
She acccp teJ the gave l
from Ira J. Kodner, M.D. ,
who completed his one-year

term on June 30. Kodner
presided over the annual
meeting of WUMCAA in
May, where he presented the
new s late of officers and Ex
ecutive Council members for
1992-'93 as recommended
by the nominating commit
tee . The nominations were
unanimously approved.
The new officers and
members are: vice-president
- David W. Ortbals, M.D.
'70; secretary-treasurer 
Lewis C. Fischbein , M.D.
' 74; council membe rs to
serve three-year term s 
Stephen A. Ka menetzky,
M. D. '70; William 1. Ross ,
M.D. '72; Ernest T. Rouse,
Ill, M .D . '71; mily L.
Smith, M .D. '68; and James
Bo brow, M .D .. fo rm er house
staff; out-of-town council
members - S te phen W .
Van Meter, M .D. ' 67 ;
S haron Vall Meter, M. D.
'67 ; Captai n Stephen 8 .
Lew is. M .D . '66; Jonathan
M. M a nn, M.D . '74; and
G ary S. Rac helefsky . M.D .
' 67.
Alumni asso ciation mem 
b rs acce pted a report of the
financial assi stance their or
ganization had provided dur
ing the year:
• $ 120,000 to the Dis tin
gui s hed A lumni Scholars hip
Fund .
• E mergency and transi
tion loans to students via the
Alumni Student Loan Fund.
• $7 50 each for the stu
dent acti vity funds of the
fi rst-year class and the sec
ond-year class.
• S4.760 to cover the bud
get of the school' s chapter of

the American Medic al Stu
dents Association.
• $15,000 for the Young
Scientist Program that pro
vides the opportunity for
economically di sadv antaged
high sc hool students to
spend a summer working in
a laboratory under the direc
tion of a student in the Medi
cal Scie nt is t T raining
Program.
• $ I,350 for the Drug
Educ ation Project, in which
medical students make pre
sentations to elementary
sc hool students about th e
effects of drug use.
• $5,000 to the Academic
Soci eties that allow faculty
and students to participate
togethe r in educational and
so cial events.
• $ 5,000 for a reception
fo r g radu ates a nd their fami
lies.
• $3 0,000 to the Alumni
Endowed Professorship Pro
gram. Curre ntly, there are
four such professorsh ips .
They are held by Jeffrey 1.
Gordon , M.D .; Alan L.
SchwartL, Ph. D .; D o uglas E.
Be rg, Ph.D .; and Robert D.
Sc hreiber, Ph. D .
• $60,000 to COnLinuing
Medical Ed ucati o n .
Kodner reported that the
Executive C ounc il also de
voted attention to student
related co ncerns and student
projects and to the avenues
via which alumni can play
role ' in recruiting and advis
ing students and in providin g
first- and second-year stu
de nts with greater exposure
to clinic al medicine.

l
Challenge Mel,
Anllual Fund A
es~

he Sch oo l of
Medi cine's annual
fUl1ll dri ve - th e
yearl y so lic itation of support
for the school - th at ended
at th e cl ose of Jun e, res ulted
ina gift total of $942,4 18 for
fi sc al 1992. Accordin g to
Hann ele Haapal a, director of
annual giving. rully 69 per
ce nt of the total was given
by alum ni.
Th e annu al fund set high
wate r mar ks in severa l arcas
thi s year. Overal l, al umni
ga ve eight percent more thall
they did in fi scal 1991 , and
participati on was partic ularly
not abl e among graduates of
the Heallh Ad minis trat ion
Program (HAP) and the Pro
gram in Phys ica l Therapy
(PT ). Slightl y more than 30
percent of all HAP al umni
participated in the an nual
fund program . and more than
32 percent of PT grads re
sponded. Among physician
graduates of the sc hool , al
most 35 perce nt made g ifts
during fisca l 1992.
Haapala al so noted that
membership in all donor
clubs - from the Century
Club for donors of $100 or
more to the Eli ot Society fo r
donors of at least $ 1,000 
increased during fisca l yea r
1992. Eli ot Society me mbers
numbered 3 83, compared to
367 during the prev ious yea r.
ParI of th at increa se wa s
attributable to the Asa C. and
Doroth y W . Jon es C hal

lenge, an effort to enl ist at
least 100 new memhcrs in
the Eli ot Soc iety. Th e chal
lenge was met, wit h 103 new
members named during the
yea r.
The ch al lenge was issu ed
by Dr. and M rs . Jones, long
time supporters of the
sc hoo l, who match ed gifts to
the annua l fund up to
$ 100,000. Jon es, M.D. '42,
ce lebrated hi s 50th re union
thi s year.

Scbolal"shil)S
HOllor

'B eloved
Tea(~hers
he alu mni associa
tion has sd l:C!cd the
fO Ll r d i ~ t in g u i:-,h('d
alu mni in whose namc!> the
first cyc le of th e Distin
gui shed Alu mni Scholars hip
Program will be com pleled.
Hanne!e Haapala. direc tor of
annual givin g in the Office
of Alumni and De vel opment
Programs, ca lb the sch olar
shi ps a way to recog ni ze
"beloved teachers,"
Honored wi th sc holar
\ hips in th eir names are: I.
Je rom e FIance. M.D. ' 35 ,
cl inical profes\or of medi
cin e; David Goldring, M.D.
'40 ( 19 14- 199 2). professor
emeritu s of ped iatri cs:
Charl es W . Parker, M.D.
'53 , professor of med ic ine
and molecul ar mi crobi o logy:
and Jessie L. Tern berg, M .D .
'53. professor of pedi atri cs
and pedi atric surgery .

The se four hi gh ly re 
garded alumni - also out
standin g members of the
fac ulty - j oin the 12 others
for whom ex istin g scholar
ships ha ve been establ ished.
The sch olarsh ips are the
School of Mcdi ci ne's major
meri t-based schol arship pro
gram, funded to a large ex
tent by annu al gift s from
alumni and others. Each
na med sc holarship pro vides
a fre shm an recipi ent with
$10,000 toward tuiti on cos ts.
The medical schoo l the n
matches the gran t up to the
fu ll amount of tu ition. As
suming th at the students
named rem ain in good stand
ing, the sc hola rships co n
tin ue for fo ur years of
medica l edu cati on.
Establ ished by the al um ni
assoc iati on in 1989. lhc
!>chol ars hips are not based on
fi nanc ial need bu t on aca
demic merit and the excep
tiona) pe r~ o na l qualiti es that
cont ribute to th e s u cce s ~ ru l
pmctice of med icine.
( .A' ).....I
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fairs, th e trip was a success,
rsin reports.
Ed~' ard Alun Ha r ris,
M.D. '37, serves as pro fes
sor emerit us in the Depart
ment of Pedi at rics at the
Uni ve rsity of Alabama Col
lege of Medic ine. He is ac
tive as a medica l consultant
to the disa bil ity determ in a
tion un it of the Alabama
State Departm ent of Educa
ti on. Wid owed sin ce 1984,
he reports that he has fi ve
grandchildre n and one great
grand ~ on .

J. Robert Mangum,
M.D. ' 38. w ri te~ that he
pl ans to attend the 55 th year
annu al reuni on in 1993 . He
re sides in Nampa, !D .
F. Dale Wilson, M.D.
'38. retired from the pract ice
o f medicine at tb e end of
1991 and remai ns in good
health in Dave nport. IA.
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J rwin B. Horwitz, M.D.
'29, writes that he is "just
loa fing toward my 88th
birthday and enj oying he ing
lazy,"

O. EUiott Ursin, M.D.
'36, an d hi s wife rece ntly
traveled with a sma ll group
to Ru ssia. Sponsored by St.
Ol af Coll ege and led by a
profe ssor of Far Eastern af

Philip T. Shahan, M.D.
'42. ret ired from practi ce at
the end of January 1992 .
Alexandel' Ling, M.D.
'44, has retired after 16 years
as senior me mber of North
easte rn Oh io Neuros urgical
Associat es. the largest and
oldest neurosurgi cal gro up in
melrop()li lan Cleve land .
Truett Bennett, M.D.
'45. retired from his ENT
practice in Hawai i an d
moved hack to North Caro
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lina. There, he found a need
for a phy s ician in the tiny
(population: 600) town of
Oriental, so he began a so lo
general practice. He writes,
"I ani enjoying the change
very much ."
Paul F. Brown, M.D.
'47, has retired from practice
but does occasional locum
tenens.
Robert R. Lyle, M.D.
'49, reports that he continues
to enjoy practicing family
medicine three days a week
and that he has 10 grandchi 1dren.
William N. Chambers,
M.D. '50, retired from limited practice in December of
1991 . Since the death of hi s
wife, Fran, in 1986, he has
traveled the world solo and
say s he is "lucky to have a
few good friends," with
whom he plays bridge,
poker, chess and the stock
market.
Adrian M. Ostfeld, M.D.
'51, the Anna M.R. Lauder
Professor of Epidemiology
and Public Health and Medicine at Yale University
School of Medicine, ha s
been elected a fellow of the
Royal Society of Medicine
in London. Ostfeld, recognized for distinguished contributions to the biomedical
sc iences , is one of 230 professionals in geriatrics and
gerontology with society
membership.
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Gordon R. Heath, M.D.

'52, practices pediatric s in
Lakeland, FL.
Galen B. Cook, M.D.
'55, president of Medical
Logic International, (publisher of 52 item s of clinical
software) has announced an
agreement with SRC Systems of San Antonio that
will expand the exposure of
the company's products

Nutrition . The new chair is
the first ever endowed in nutrition at Harvard Medical
School. Walker ha s for 10
years been professor of pediatrics and chief of the combined pediatric
gastrointestinal and nutrition
unit at Children's Hospital
and Massachusetts General
Hosp ital.
I_ouis P. Dehner, M.D.

'66, has been named paJoseph V. LeBlanc, III,
M.D. '56, has retired from
the post of corporate medical
director at Phillips Petroleum Co. in Bartlesville, OK,
where he and his wife continue to resi de.

'60s and '70s
James F. Jekel, M.D.
'60, is the co-author (with
David Allen, M.D. ) of the
book, Crack: The Broken
Promise, published by St.
Martin's Press (New York,
1991 ).
Robert H. Waldman,
M.D. '63, has accepted the
position of vice-president for
Graduate Medical Education
and International Programs
at the Assoc iation of American Medical Colleges.
W. Allan Walker, M.D.

'63, prompted by his sense
of having been out of touch
with the Midwest for 25
years, reports on his progress
at Harva rd Medical School:
He has been named to the
Conrad Taff Professorship of

thologi st- in-chief at SL
Louis Children's Hospital.
Gary Rachelefsky, M.D.

expert in suicidology at the
psychiatry department of the
State University of New
York at Stony Brook , Rich
joined eight of hi s colleagues
at that institution on the list.
Eric Zurbrugg, M.D.

'70, and Jo Zurbrugg, M.D.
'70, moved to Hilton Head
Is land Jate in 199 1 with
plans to start a pediatrics/
pediatric neurology practice
together there. The new of
fice address: Hi Iton Head
Pediatrics, 21 Mathews
Drive, Suite #10, Hilton
Head Island, SC 29926.

' 67, writes that he is still
happily married after 25
years a nd the father of three
girls: Holly, Cara and Lindsay. He is in the private
practice of allergy and immunology, a clinical professor a t UCLA and associate
director of the allergy-immunology training program at
UCLA.
Hunter Heath, III, M.D.
'68, left the Mayo Clinic in
Ro c hester, MN, on November J, J99 I . After 17 years
in the Endocrine Research
U nit there, he left to become
chief of the division of endocrinology and metaboli sm in
the Department of Medi cine
at the University of Utah
Medical Center in Salt Lake
City.
Charles Rich, M.D. '69,
was among those physicians
named in the recently released first edition of The
Best Doctors ill America,
publi shed by Woodward/
White Inc .. Aiken Sc. An

C. Leon Partain, M.D.
'75, has been named chairman of the Department of
Radiology and Radiological
Sciences at Vanderbilt Uni
versity Med ica l Center and
radiologist-in-chief at
Va nderbilt University Hospi 
tal in Nashville, TN.
Toby L. Litovitz, M.D.
'76, authored a paper com
paring pediatric poisoning
hazard s in 3.8 million expo
sure incidents and found that
iron su pplement pill s - often mi sta ken by c hildren for
candy - were the s ingle
most frequent cau se of pedi
a tric unintentional ingestion
fatalities. The New York
Tim es reported the findings
published in the journal
Pediatrics.
Gary L. Baker, M.D.
'77, was certified by the
American Board of Plastic
Surgery and received the
Certificate for Added Qualification in s urgery of the
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hand from the American
Board of Surgery in 1991.
Previollsly , Baker was certi
fied by the American Board
of Internal Medicine and the
American Board of Surgery.
An assistant professor of
plastic surgery ilt the Univer
sity of Kan sas Medical Cen
ter in Kan sas City, KS ,
Baker is one of two pla stic
surgeons in the nation certi
fied by four sepa rate ABMS
sanctioned board s.
Carol Marie Mitchell,
M.D. '79, was married to
Thomas L. Marcu s on Octo
ber 18, 1991 , in Waterloo .
IL. She writes that s he a nd
her husband eloped 70 years
to the day after her grandpar
ents did the same thing.

'80s
Rita M. Willett, M.D.
'81, announces the birth of
her son, Nathan K. Willett,
born January 20, 1991.
Willett is ass istant professor
in the general internal medi
cine division at the Medical
College of Virginia.
Stuart Sherman, M.D.

'82, serves as assistant direc
tor of medicine and director
of pancreaticobiliary
endoscopy at the UCLA
School of Medicine. He was
married to the former Leslie
Derus on October S, 1991,
and the couple expected their
first child well before this
note reached print.

Douglas Alan Munro,
M.D. '83, writes that he was
"finally" married in June of
1991 in Colorado. He contin
ues hi s private practice of
radiology in Santa Rosa , CA.
Paul Detjen, M.D. '84,
ha s opened offices in
Winnetka, IL, for the prac
ti ce of adu It and ped iatric
allergies and immunology.
He is a board-certified aller
gis t and also is certified by
the American Board of Inter
nal Medicine.
Sari R. Levine, M.D.
'85, writes from Mountain
View, CA: "Nothing could
be better. I have a great job,
wonderful associates and am
enjoying each moment of
post-residen cy private prac
tice. I think I've found para
dise."
Rachel Haft, M.D. '86,
reports that she is "recently
and happily " married to Jef
frey Brown . After visiting
Israel a nd Egypt o n their
honeymoon, the co uple now
res ide in Bos ton.
Bill Frank, M.D. '87, ha s
recently fi ni s hed hi s derm a
tology res idency at Harvard
Medical School.

FOHMER HOUSE
S T A F F N () T 'f : S
Andrew Epstein, M.D.,
F.H.S. in cardiology , has
been promoted to professor
of medicine in the divi s ion
of cardiovascular di sease at

the University of Alabama at
Birmingham .
Ronald B. Miller, M.D.,
F.H.S. in internal medicine,
left the private practice of
nephrology to spend the
1989- '90 academic year as
visiting scholar at the Center
for Clinical Medical Ethics
of the University of Chicago
and to direct the Program in
Medical Ethics at the Uni
versity of California
Irvine.

Bartolomeo J. Castelli,
HA '82, and hi s wife ,
Deborah , had their first
child, Vincent Joseph, on
May 3, 1991.
Dale S. St. Arnold, HA

'86, rece ntly was appointed
pres ident and chief execlItive
officer of Mount Carmel
Health in Columbus, OH.

Edgar W. Percy, M.D.,
F.H.S. in pediatrics, has
been in private practice in
Lake Charles, LA for 3 I
years. He has been married
for S2 years to his childhood
sweetheart, the former Mary
Alice Albright, and the
couple have two children.
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Margaret Etheridge, HA
, 73 , director of the Veterans
Affairs Medical Center in
Grand Is land , NE , has been
named that comm unity ' s
Woman of the Year for
1991.
William C. Schoenard,
HA '75, has been named to
Who's Who in Finance and
Indu stry and Who's Who in
th e Midwest. He is executive
vice presi dent and chief op
erating officer of SSM
Health Care System in St.
Loui s.

B. J. Kerr
Bernard J. Ke rr, J r.,
H A ' 88, a captain in the U .S.
Air Force Medical Service
Corps, has been selected for
promotion to major. He com
pleted the doctor of educa
tion degree at
SIU -Edwa rdsville in 1991 .
and has recently finished an
A ir Force-sponsored post
doctora l fellowship in man
aged health care.
Connie K ral Craigm ile,
PT '87, and her husband,
Todd , announce the birth of
a daughter, Monica Lynn,
born in July 1991.

!I
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Elamay Mueller Jeffery,
OT '48, and her hu s band

I

so ld their California home
and tlew off to Germany in
early 1990 for 14 month s.
Upon their return, they
settled in Tucson.

George F. Helmkamp,
M.D. '28, of Palm Springs,

Laurie N. Schwarze, OT
'82, is director of rehabilita
tion services in Queens, New
York City. She and her hus
band planned to move to
Dallas by the time this up
date reaches print.
I

1

Edna Sanders Eimers,
NU '36, celebrated her 50th
wedding anniversary on
January 26, 1991, with all 24
descendants pre sen t.

MEMORIAM

CA, died June 25, 1991.

Carl G. Harford, M.D.
' 33, and for many years a
faculty member at the
School of Medicine died
Monday, May 18, 1992 after
a long illness. A speciali st in
infectious diseases, he pio
neered the study of viruses
and worked to evaluate peni
cillin in the 1940s. A son,
two daughters, a sister, a
brother and three grandchil
dren survive him.

Hope Mitchell Lewis,
NU '36, plans a trip to Saudi
Arabia in October to vi si t
her daughter there.

Helen Bennett Paust,
NU '48, planned to retire in
J 990 but had an opportunity
to work with post-traumati c
stress di sorde r patients in
Austin, TX, and accepted it.
S he says she plan s to see
how she feels about work at
the end of 1992.

Mildred Lehman Hill,
NU '53, asks that any alums
interested in a reunion in
1993 write to her with sug
gested dates at #46 Whitmer
Drive , Chesterfield, MO
63017.
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David M. Goldring, M.D.
David M. Goldring,
M.D. '40, the renowned pe
diatric cardiologist who first
became an in struc tor in pedi
atrics at the School of Medi
cine in 1940, died from lung
cancer on May 26, 1992, at
hi s home in Univers ity City.
He had been a staff pedi atri
cian at St. Loui s Children's
Hospital for more than 40
years.

Goldring founded the pe
diatric cardiology division at
the hospital a nd, in 1956,
helped design a heart-lung
machine that first enabled
surgeons to perform open
heart surgery to correct con
genital deformities in the
hearts of children. He also
pioneered resea rch to define
the causes of high blood
pressure in children.
Des pite his outstanding
contributions to research,
" he perhaps will be remem
bered most as a remarkably
kind and gentle physician
amI teacher," says Arnold
Strauss , M.D., direc tor of
pediatric cardiology at St.
Louis Children's Hospital.
An endowment fund for
studies of congenital heart
disease will be established in
Goldring's memory, Strauss
says.
In 1985, he was presented
with the medical school's
Alumni/Faculty Award , and
in 1991, Goldring became
the first recipient of the St.
Loui s Children's Ho spital
medical s taff's highest
honor, the Distinguished
Service Award. He was ac
tive in many he a lth organiza
tions, serving as director of
the Mi ssouri Rheumatic Fe
ver Program from 1949 to
1955 ; secretary treasurer of
the American Pediatric Soci
ety, and pres ident of the St.
Louis Pediatri c Society.
A memorial serv ice was
held on Sunday, June 28 at
Graham Chapel, followed by
a reception at Whittemore
House. Among the survivors
are his wife, Evelyn; a

daughter, Nancy ; two sons,
Steven and Peter; two grand
children, and his brother,
Sidney Goldring, M.D.,
former head of neurosurgery
at the medical sc hool.

James W. Willoughby,
M.D. '47, died on M ay 27,
1992 . He practiced in aller
g ic diseases in Liberty, MO .

Maurice F. Attie, M.D.
'75, was killed on Sunday,
June 5 , 1992, when he was
struck by a car as he bi
cycled near his home in Bala
Cynwyd, PA . An avi d bicy
clist, Attie was wearing a
helmet when he was hit from
behind . An associ a te profes
sor at the University of
Pennsylv ania, he was a
highly regarded researcher in
endocrinology. In 1991, he
won hi s medical sc hool's
award for excellence in
teaching. He is s urvived by
his wife, Barbara; daughters
Alisa, a premed student, a nd
Jessica; a so n, Michael; hi s
parents; a brother and a sis
ter. •

Medieal Alumni
Classes of '33, '38, '43, '48, '53,
'58 , '63, '68, '73, '78, '83
Mark your calendars.
May 6-8 1993
Put Reunion '93 on your
schedule now!
Details and registration materials
will follow in January.
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An unusually cool alld pLeasant summer prompted thoughts of
all early fall at the medical school and stirred memories of
scenes like this olle from Last year.
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